← Eichor
Study identifier: NCT07351123 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Assessment of Treatment Variability for Pelvic Ring Fragility Fractures

Condition: Pelvic Fractures · Fragility Fractures of the Pelvis (FFP)  ·  Sponsor: University of Maryland, Baltimore

PhaseN/A
Planned participants120
Who can joinAll sexes, 60 Years to no upper limit
Healthy volunteersNo

About this study

Fragility fractures of the pelvic ring are a common injury associated with poor patient outcomes and high healthcare costs. Management of these injuries is evolving with increasing frequency of operative stabilization of the pelvic ring, despite a lack of evidence supporting operative versus nonoperative treatment. This multicenter prospective cohort study will evaluate 120 patients to determine the feasibility of a randomized controlled trial comparing operative and nonoperative treatment, by evaluating patient willingness to enroll in a trial, surgeon willingness to randomize their patients' treatment, and the completeness of data collection.

This description comes directly from the study's public registry record.

Talk to the study team

Mark Gage, MD  ·  410-328-1868  ·  mgage@som.umaryland.edu

Heather Phipps, MPS  ·  hphipps@som.umaryland.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Maryland, BaltimoreBaltimore, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07351123